Design Therapeutics reported earnings of -$ 0.32 per DSGN share on Nov 4, 2026, falling short of analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | -$ 0.34 |
| Earnings Per Share (Surprise) | -$ 0.32 (+$ 0.02406) |
| Last Year's EPS | -$ 0.31 |
| EPS YoY Change |
Out of the last 27 earnings reporting periods, Design Therapeutics beat analysts’ expectations 16 times and fell short of expectations 7 time(s). Design Therapeutics reported earnings per share of -$ 0.32 in the last report surpassing an estimated EPS of -$ 0.34 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.34 | -$ 0.32 | -$ 0.30 | |
| Aug 3, 2026 | -$ 0.34 | -$ 0.32 | -$ 0.34 | |
| Apr 28, 2026 | -$ 0.36 | -$ 0.29 | -$ 0.31 | |
| Mar 9, 2026 | -$ 0.38 | -$ 0.27 | -$ 0.24 | |
| Nov 5, 2025 | -$ 0.34 | -$ 0.30 | -$ 0.23 | |
| Aug 7, 2025 | -$ 0.32 | -$ 0.34 | -$ 0.21 | |
| May 7, 2025 | -$ 0.28 | -$ 0.31 | -$ 0.20 | |
| Mar 10, 2025 | -$ 0.28 | -$ 0.24 | -$ 0.21 | |
| Nov 7, 2024 | -$ 0.26 | -$ 0.23 | -$ 0.28 | |
| Aug 5, 2024 | -$ 0.25 | -$ 0.21 | -$ 0.36 | |
| May 8, 2024 | -$ 0.28 | -$ 0.20 | -$ 0.35 | |
| Mar 19, 2024 | -$ 0.32 | -$ 0.21 | -$ 0.31 | |
| Nov 13, 2023 | -$ 0.42 | -$ 0.28 | -$ 0.32 | |
| Aug 14, 2023 | -$ 0.41 | -$ 0.36 | -$ 0.27 | |
| May 9, 2023 | -$ 0.37 | -$ 0.35 | -$ 0.24 | |
| Mar 14, 2023 | -$ 0.34 | -$ 0.31 | -$ 0.20 | |
| Nov 3, 2022 | -$ 0.28 | -$ 0.32 | -$ 0.21 | |
| Aug 8, 2022 | -$ 0.25 | -$ 0.27 | -$ 0.14 | |
| May 9, 2022 | -$ 0.22 | -$ 0.24 | -$ 0.31 | |
| Mar 10, 2022 | -$ 0.22 | -$ 0.20 | -$ 0.09 |
Design Therapeutics’s stock was trading at $ 10.34 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, DSGN’s price decreased to $ 9.67 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.32 | $ 10.34 | $ 9.67 | |
| Aug 3, 2026 | -$ 0.32 | $ 12.18 | $ 13.20 | |
| Apr 28, 2026 | -$ 0.29 | $ 12.81 | $ 15.79 | |
| Mar 9, 2026 | -$ 0.27 | $ 10.05 | $ 9.99 | |
| Nov 5, 2025 | -$ 0.30 | $ 6.24 | $ 6.87 | |
| Aug 7, 2025 | -$ 0.34 | $ 4.35 | $ 4.28 | |
| May 7, 2025 | -$ 0.31 | $ 3.63 | $ 3.52 | |
| Mar 10, 2025 | -$ 0.24 | $ 4.92 | $ 5.33 | |
| Nov 7, 2024 | -$ 0.23 | $ 5.94 | $ 5.83 | |
| Aug 5, 2024 | -$ 0.21 | $ 4.74 | $ 4.21 | |
| May 8, 2024 | -$ 0.20 | $ 4.69 | $ 4.77 | |
| Mar 19, 2024 | -$ 0.21 | $ 2.52 | $ 2.90 | |
| Nov 13, 2023 | -$ 0.28 | $ 2.01 | $ 2.29 | |
| Aug 14, 2023 | -$ 0.36 | $ 7.68 | $ 2.17 | |
| May 9, 2023 | -$ 0.35 | $ 7.60 | $ 6.67 | |
| Mar 14, 2023 | -$ 0.31 | $ 7.05 | $ 7.01 | |
| Nov 3, 2022 | -$ 0.32 | $ 15.50 | $ 15.46 | |
| Aug 8, 2022 | -$ 0.27 | $ 21.93 | $ 21.99 | |
| May 9, 2022 | -$ 0.24 | $ 11.20 | $ 11.03 | |
| Mar 10, 2022 | -$ 0.20 | $ 17.56 | $ 17.25 |
Design Therapeutics released its most recent earnings reports in November 2026, August 2026, April 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Design Therapeutics beat analysts’ expectations during the last earnings period by
